Cover Image
Market Research Report

Surgical Site Infection Market by Product, by Phase, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013 - 2023

Published by Prescient & Strategic Intelligence Private Limited Product code 666066
Published Content info 177 Pages
Delivery time: 2-3 business days
Price
Back to Top
Surgical Site Infection Market by Product, by Phase, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013 - 2023
Published: June 1, 2018 Content info: 177 Pages
Description

Title:
Surgical Site Infection (SSI) Market by Product (Antibiotic Prophylaxis Products, Antiseptics & Disinfectants, Wound Care Dressings, Surgical Drapes, Surgical Staff Clothing, Patient-Warming Products, Wound Care Supplementary Products, Clippers, Wound Irrigation Products), by Phase (Intraoperative Phase, Preoperative Phase, Postoperative Phase), by End User (Hospitals, Ambulatory Surgical Centers [ASCs], Clinics), by Geography (U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, Australia, South Korea, Brazil, Mexico, Saudi Arabia, South Africa)- Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023.

"Global surgical site infection market is forecasted to reach $5.9 billion by 2023."

The market growth can be attributed to the development of technologically advanced products and growing geriatric population. Furthermore, increasing number of surgical procedures and rising incidence of SSIs are boosting the market growth.

Insights on market segments

Antibiotic prophylaxis products generated the largest revenue in the surgical site infection market in 2017. In most cases, patients' sensitivity to certain drugs creates the need for specific antibiotics, which, in turn, adds to the treatment cost. Owing to this factor, antibiotic prophylaxis products continue to be in high demand in the market. However, the fastest growth in the market during the forecast period is expected from the antiseptic and disinfectant product category, with a CAGR of 7.4%.

Among all phases, the demand for products for the intraoperative phase is expected to exhibit the fastest growth in the surgical site infection market, at a CAGR of 6.6%, during the forecast period. This can be attributed to the wide usage of SSI preventive products during the intraoperative phase, as the chances of contamination to open wounds are the highest during this phase. Also, due to this reason, healthcare facilities are increasingly complying with the World Health Organization (WHO) guidelines that suggest measures to prevent infections.

Hospitals have been contributing the largest revenue to the surgical site infection market, owing to increase in the number of surgeries and a significant increase in the number of hospitals on a global level, which is further leading to the increased use of products that help prevent surgical site infections.

Market is projected to witness the fastest growth in Asia-Pacific (APAC)

During the forecast period, the surgical site infection market is expected to witness the fastest growth in APAC, at a CAGR of 7.7%. The APAC surgical site infection market is also expected to reach $1,492.8 million by 2023. The market growth in APAC is mainly driven by growing geriatric population, rising incidence of SSIs, increasing adoption of technologically advanced products, and improving healthcare infrastructure.

According to the UN publication World Population Ageing 2017, in Asia, the number of people aged 60 years or above is estimated to increase from 549 million in 2017 to nearly 1.3 billion in 2050. Also, there is a high adoption rate of technologically advanced products in Japan. Besides, the country is witnessing an increase in its geriatric population. These factors are expected to continue driving the growth of the surgical site infection market market in Japan.

According to Japan Nosocomial Infections Surveillance (JANIS), a national surveillance program organized by Japan's Ministry of Health, Labour and Welfare (MHLW) in 2017, there were 117,209 cases of methicillin-resistant Staphylococcus aureus (MRSA) infection in 2012, which increased to 177,768 in 2016. Thus, increase in surgical site infections in Japan is boosting the demand for products that help fight these infections.

Key players are seeking partnerships to increase their market share

In order to increase their market share, key players of the surgical site infection industry are entering into partnerships. For instance, in January 2018, Molnlycke Health Care AB entered into a partnership with Tissue Analytics, a developer of digital wound-imaging platforms. With this partnership, both the companies intend to jointly develop and commercialize innovative digital solutions (such as comprehensive clinical decision support tools) for wound care professionals.

Some of the other key players operating in the surgical site infection market are: 3M Company, STERIS plc, Stryker Corporation, Medtronic plc, Prescient Surgical Inc., Covalon Technologies Ltd., Surgical Site Infection Prevention LLC, HARTMANN GROUP, B. Braun Melsungen AG, and Becton, Dickinson and Company.

GLOBAL SURGICAL SITE INFECTION (SSI) MARKET SEGMENTATION

Market Segmentation by Product

  • Antibiotic Prophylaxis Products
    • Antiseptics and Disinfectants
    • Wound Care Dressings
    • Surgical Drapes
    • Surgical Staff Clothing
  • Patient-Warming Products
    • Wound Care Supplementary Products
    • Clippers
    • Wound Irrigation Products
    • Others

Market Segmentation by Phase

  • Intraoperative Phase
    • Surgical Drapes
    • Surgical Staff Clothing
    • Wound Care Dressings
    • Patient-Warming Products
    • Antiseptics and Disinfectants
    • Wound Care Supplementary Products
    • Others
  • Preoperative Phase
    • Antibiotic Prophylaxis Products
    • Antiseptics and Disinfectants
    • Clippers
    • Others
  • Postoperative Phase
    • Wound Care Dressings
    • Wound Care Supplementary Products
    • Wound Irrigation Products
    • Others

Market Segmentation by End User

  • Hospitals
  • Ambulatory Surgery Centers (ASCs)
  • Clinics
  • Others

Market Segmentation by Geography

  • North America Surgical Site Infection Market
    • By Product
    • By Phase
    • By End User
    • By Country - U.S. and Canada
  • Europe Surgical Site Infection Market
    • By Product
    • By Phase
    • By End User
    • By Country - Germany, U.K., France, Italy, Spain, and Rest of Europe
  • Asia-Pacific (APAC) Surgical Site Infection Market
    • By Product
    • By Phase
    • By End User
    • By Country - Japan, China, India, Australia, South Korea, and Rest of APAC
  • Rest of the World (RoW) Surgical Site Infection Market
    • By Product
    • By Phase
    • By End User
    • By Country - Brazil, Mexico, Saudi Arabia, South Africa, and Rest of RoW

SSI Incidence and Forecast by Country

  • U.S. SSI Incidence and Forecast
    • By Surgery Type
  • Canada SSI Incidence and Forecast
    • By Surgery Type
  • Germany SSI Incidence and Forecast
    • By Surgery Type
  • U.K. SSI Incidence and Forecast
    • By Surgery Type
  • France SSI Incidence and Forecast
    • By Surgery Type
  • Italy SSI Incidence and Forecast
    • By Surgery Type
  • Spain SSI Incidence and Forecast
    • By Surgery Type
  • Japan SSI Incidence and Forecast
    • By Surgery Type
  • China SSI Incidence and Forecast
    • By Surgery Type
  • India SSI Incidence and Forecast
    • By Surgery Type
  • Australia SSI Incidence and Forecast
    • By Surgery Type
  • South Korea SSI Incidence and Forecast
    • By Surgery Type
  • Brazil SSI Incidence and Forecast
    • By Surgery Type
  • Mexico SSI Incidence and Forecast
    • By Surgery Type
  • Saudi Arabia SSI Incidence and Forecast
    • By Surgery Type
  • South Africa SSI Incidence and Forecast
    • By Surgery Type
Table of Contents

Table of Content

Chapter 1. Research Background

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Research Scope
    • 1.3.1. Market Segmentation by Product
    • 1.3.2. Market Segmentation by Phase
    • 1.3.3. Market Segmentation by End User
    • 1.3.4. Market Segmentation by Geography
    • 1.3.5. Analysis Period
    • 1.3.6. Market Data Reporting Unit
      • 1.3.6.1. Value
  • 1.4. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
  • 2.2. Primary Research
    • 2.2.1. Breakdown of Primary Research Respondents
      • 2.2.1.1. By region
      • 2.2.1.2. By industry participant
      • 2.2.1.3. By company type
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1. Definition of Market Segments
    • 4.1.1. By Product
      • 4.1.1.1. Antibiotic prophylaxis products
      • 4.1.1.2. Antiseptics and disinfectants
      • 4.1.1.3. Clippers
      • 4.1.1.4. Patient-warming products
      • 4.1.1.5. Wound care dressings
      • 4.1.1.6. Wound care supplementary products
      • 4.1.1.7. Surgical drapes
      • 4.1.1.8. Surgical staff clothing
      • 4.1.1.9. Wound irrigation products
      • 4.1.1.10. Others
    • 4.1.2. By Phase
      • 4.1.2.1. Preoperative phase
      • 4.1.2.2. Intraoperative phase
      • 4.1.2.3. Postoperative phase
    • 4.1.3. By End User
      • 4.1.3.1. Hospitals
      • 4.1.3.2. Clinics
      • 4.1.3.3. Ambulatory surgery centers (ASCs)
      • 4.1.3.4. Others
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
      • 4.2.1.1. Rising incidence of SSIs
      • 4.2.1.2. Increasing number of surgical procedures
      • 4.2.1.3. Development of technologically advanced products
      • 4.2.1.4. Growing geriatric population
      • 4.2.1.5. Impact analysis of drivers on market forecast
    • 4.2.2. Restraints
      • 4.2.2.1. Low preventive measures for nosocomial infections in developing nations
      • 4.2.2.2. Lack of awareness about SSIs
      • 4.2.2.3. Impact analysis of restraints on market forecast
    • 4.2.3. Opportunities
      • 4.2.3.1. Increasing initiatives by various organizations
      • 4.2.3.2. Collaborations to prevent SSIs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Buyers
    • 4.3.2. Bargaining Power of Suppliers
    • 4.3.3. Intensity of Rivalry
    • 4.3.4. Threat of New Entrants
    • 4.3.5. Threat of Substitutes

Chapter 5. SSI Incidence and Forecast

  • 5.1. U.S. SSI Incidence and Forecast by Surgery Type
  • 5.2. Canada SSI Incidence and Forecast by Surgery Type
  • 5.3. Germany SSI Incidence and Forecast by Surgery Type
  • 5.4. U.K. SSI Incidence and Forecast by Surgery Type
  • 5.5. France SSI Incidence and Forecast by Surgery Type
  • 5.6. Italy SSI Incidence and Forecast by Surgery Type
  • 5.7. Spain SSI Incidence and Forecast by Surgery Type
  • 5.8. Japan SSI Incidence and Forecast by Surgery Type
  • 5.9. China SSI Incidence and Forecast by Surgery Type
  • 5.10. India SSI Incidence and Forecast by Surgery Type
  • 5.11. Australia SSI Incidence and Forecast by Surgery Type
  • 5.12. South Korea SSI Incidence and Forecast by Surgery Type
  • 5.13. Brazil SSI Incidence and Forecast by Surgery Type
  • 5.14. Mexico SSI Incidence and Forecast by Surgery Type
  • 5.15. Saudi Arabia SSI Incidence and Forecast by Surgery Type
  • 5.16. South Africa SSI Incidence and Forecast by Surgery Type

Chapter 6. Global Market Size and Forecast

  • 6.1. By Product
  • 6.2. By Phase
    • 6.2.1. Global Intraoperative SSI Market, by Product
    • 6.2.2. Global Preoperative SSI Market, by Product
    • 6.2.3. Global Postoperative SSI Market, by Product
  • 6.3. By End User
    • 6.3.1. Number of End Users Utilizing SSI Preventive Products
  • 6.4. By Region

Chapter 7. North America Market Size and Forecast

  • 7.1. By Product
  • 7.2. By Phase
    • 7.2.1. North America Intraoperative SSI Market, by Product
    • 7.2.2. North America Preoperative SSI Market, by Product
    • 7.2.3. North America Postoperative SSI Market, by Product
  • 7.3. By End User
    • 7.3.1. Number of End Users Utilizing SSI Preventive Products
  • 7.4. By Country

Chapter 8. Europe Market Size and Forecast

  • 8.1. By Product
  • 8.2. By Phase
    • 8.2.1. Europe Intraoperative SSI Market, by Product
    • 8.2.2. Europe Preoperative SSI Market, by Product
    • 8.2.3. Europe Postoperative SSI Market, by Product
  • 8.3. By End User
    • 8.3.1. Number of End Users Utilizing SSI Preventive Products
  • 8.4. By Country

Chapter 9. APAC Market Size and Forecast

  • 9.1. By Product
  • 9.2. By Phase
    • 9.2.1. APAC Intraoperative SSI Market, by Product
    • 9.2.2. APAC Preoperative SSI Market, by Product
    • 9.2.3. APAC Postoperative SSI Market, by Product
  • 9.3. By End User
    • 9.3.1. Number of End Users Utilizing SSI Preventive Products
  • 9.4. By Country

Chapter 10. RoW Market Size and Forecast

  • 10.1. By Product
  • 10.2. By Phase
    • 10.2.1. ROW Intraoperative SSI Market, by Product
    • 10.2.2. ROW Preoperative SSI Market, by Product
    • 10.2.3. ROW Postoperative SSI Market, by Product
  • 10.3. By End User
    • 10.3.1. Number of End Users Utilizing SSI Preventive Products
  • 10.4. By Country

Chapter 11. Competitive Landscape

  • 11.1. Market Share Analysis of Key Players
  • 11.2. Product Benchmarking of Key Players
  • 11.3. Global Strategic Developments of Key Players
    • 11.3.1. Mergers and Acquisitions
    • 11.3.2. Partnerships
    • 11.3.3. Other Developments

Chapter 12. Company Profiles

  • 12.1. Global Key Players
    • 12.1.1. 3M Company
      • 12.1.1.1. Business overview
      • 12.1.1.2. Product and service offerings
      • 12.1.1.3. Key financial summary
      • 12.1.1.4. Strategic growth plans
    • 12.1.2. B. Braun Melsungen AG
      • 12.1.2.1. Business overview
      • 12.1.2.2. Product and service offerings
      • 12.1.2.3. Key financial summary
      • 12.1.2.4. Strategic growth plans
    • 12.1.3. Becton, Dickinson and Company
      • 12.1.3.1. Business overview
      • 12.1.3.2. Product and service offerings
      • 12.1.3.3. Key financial summary
      • 12.1.3.4. Strategic growth plans
    • 12.1.4. STERIS plc
      • 12.1.4.1. Business overview
      • 12.1.4.2. Product and service offerings
      • 12.1.4.3. Key financial summary
      • 12.1.4.4. Strategic growth plans
    • 12.1.5. Stryker Corporation
      • 12.1.5.1. Business overview
      • 12.1.5.2. Product and service offerings
      • 12.1.5.3. Key financial summary
      • 12.1.5.4. Strategic growth plans
    • 12.1.6. Medtronic plc
      • 12.1.6.1. Business overview
      • 12.1.6.2. Product and service offerings
      • 12.1.6.3. Key financial summary
      • 12.1.6.4. Strategic growth plans
    • 12.1.7. Prescient Surgical Inc.
      • 12.1.7.1. Business overview
      • 12.1.7.2. Product and service offerings
    • 12.1.8. Covalon Technologies Ltd.
      • 12.1.8.1. Business overview
      • 12.1.8.2. Product and service offerings
      • 12.1.8.3. Key financial summary
    • 12.1.9. Surgical Site Infection Prevention LLC
      • 12.1.9.1. Business overview
      • 12.1.9.2. Product and service offerings
    • 12.1.10. Molnlycke Health Care AB
      • 12.1.10.1. Business overview
      • 12.1.10.2. Product and service offerings
      • 12.1.10.3. Key financial summary
    • 12.1.11. HARTMANN GROUP
      • 12.1.11.1. Business overview
      • 12.1.11.2. Product and service offerings
      • 12.1.11.3. Key financial summary
  • 12.2. Regional Players
    • 12.2.1. Nex Medical Antiseptics Srl
    • 12.2.2. Medica Europe BV
    • 12.2.3. Exoxemis Inc.
    • 12.2.4. MEDi-Lin
    • 12.2.5. Winner Medical Co. Ltd.
    • 12.2.6. Shalex Overseas Pvt. Ltd.

Chapter 13. Appendix

  • 13.1. Abbreviations
  • 13.2. Sources and References
  • 13.3. Related Report

List of Tables

  • TABLE 1: ANALYSIS PERIOD OF THE STUDY
  • TABLE 2: U.S. SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 3: CANADA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 4: GERMANY SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 5: U.K. SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 6: FRANCE SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 7: ITALY SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 8: SPAIN. SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 9: JAPAN SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 10: CHINA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 11: INDIA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 12: AUSTRALIA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 13: SOUTH KOREA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 14: BRAZIL SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 15: MEXICO SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 16: SAUDI ARABIA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 17: SOUTH AFRICA SSI INCIDENCE AND FORECAST, BY SURGERY TYPE, PER THOUSAND SURGERY PATIENTS (2013-2020)
  • TABLE 18: GLOBAL SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 19: GLOBAL SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 20: GLOBAL SSI MARKET, BY PHASE, $M (2013-2017)
  • TABLE 21: GLOBAL SSI MARKET, BY PHASE, $M (2018-2023)
  • TABLE 22: GLOBAL INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 23: GLOBAL INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 24: GLOBAL PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 25: GLOBAL PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 26: GLOBAL POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 27: GLOBAL POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 28: GLOBAL SSI MARKET, BY END USER, $M (2013-2017)
  • TABLE 29: GLOBAL SSI MARKET, BY END USER, $M (2018-2023)
  • TABLE 30: GLOBAL SSI MARKET, BY REGION, $M (2013-2017)
  • TABLE 31: GLOBAL SSI MARKET, BY REGION, $M (2018-2023)
  • TABLE 32: NORTH AMERICA SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 33: NORTH AMERICA SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 34: NORTH AMERICA SSI MARKET, BY PHASE, $M (2013-2017)
  • TABLE 35: NORTH AMERICA SSI MARKET, BY PHASE, $M (2018-2023)
  • TABLE 36: NORTH AMERICA INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 37: NORTH AMERICA INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 38: NORTH AMERICA PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 39: NORTH AMERICA PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 40: NORTH AMERICA POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 41: NORTH AMERICA POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 42: NORTH AMERICA SSI MARKET, BY END USER, $M (2013-2017)
  • TABLE 43: NORTH AMERICA SSI MARKET, BY END USER, $M (2018-2023)
  • TABLE 44: NORTH AMERICA SSI MARKET, BY COUNTRY, $M (2013-2017)
  • TABLE 45: NORTH AMERICA SSI MARKET, BY COUNTRY, $M (2018-2023)
  • TABLE 46: EUROPE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 47: EUROPE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 48: EUROPE SSI MARKET, BY PHASE, $M (2013-2017)
  • TABLE 49: EUROPE SSI MARKET, BY PHASE, $M (2018-2023)
  • TABLE 50: EUROPE INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 51: EUROPE INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 52: EUROPE PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 53: EUROPE PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 54: EUROPE POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 55: EUROPE POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 56: EUROPE SSI MARKET, BY END USER, $M (2013-2017)
  • TABLE 57: EUROPE SSI MARKET, BY END USER, $M (2018-2023)
  • TABLE 58: EUROPE SSI MARKET, BY COUNTRY, $M (2013-2017)
  • TABLE 59: EUROPE SSI MARKET, BY COUNTRY, $M (2018-2023)
  • TABLE 60: APAC SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 61: APAC SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 62: APAC SSI MARKET, BY PHASE, $M (2013-2017)
  • TABLE 63: APAC SSI MARKET, BY PHASE, $M (2018-2023)
  • TABLE 64: APAC INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 65: APAC INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 66: APAC PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 67: APAC PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 68: APAC POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 69: APAC POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 70: APAC SSI MARKET, BY END USER, $M (2013-2017)
  • TABLE 71: APAC SSI MARKET, BY END USER, $M (2018-2023)
  • TABLE 72: APAC SSI MARKET, BY COUNTRY, $M (2013-2017)
  • TABLE 73: APAC SSI MARKET, BY COUNTRY, $M (2018-2023)
  • TABLE 74: ROW SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 75: ROW SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 76: ROW SSI MARKET, BY PHASE, $M (2013-2017)
  • TABLE 77: ROW SSI MARKET, BY PHASE, $M (2018-2023)
  • TABLE 78: ROW INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 79: ROW INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 80: ROW PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 81: ROW PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 82: ROW POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2017)
  • TABLE 83: ROW POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2018-2023)
  • TABLE 84: ROW SSI MARKET, BY END USER, $M (2013-2017)
  • TABLE 85: ROW SSI MARKET, BY END USER, $M (2018-2023)
  • TABLE 86: ROW SSI MARKET, BY COUNTRY, $M (2013-2017)
  • TABLE 87: ROW SSI MARKET, BY COUNTRY, $M (2018-2023)
  • TABLE 88: 3M COMPANY - AT A GLANCE
  • TABLE 89: 3M COMPANY - KEY FINANCIAL SUMMARY
  • TABLE 90: B. BRAUN MELSUNGEN AG - AT A GLANCE
  • TABLE 91: B. BRAUN MELSUNGEN AG - KEY FINANCIAL SUMMARY
  • TABLE 92: BECTON, DICKINSON AND COMPANY - AT A GLANCE
  • TABLE 93: BECTON, DICKINSON AND COMPANY - KEY FINANCIAL SUMMARY
  • TABLE 94: STERIS PLC - AT A GLANCE
  • TABLE 95: STERIS PLC - KEY FINANCIAL SUMMARY
  • TABLE 96: STRYKER CORPORATION - AT A GLANCE
  • TABLE 97: STRYKER CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 98: MEDTRONIC PLC - AT A GLANCE
  • TABLE 99: MEDTRONIC PLC - KEY FINANCIAL SUMMARY
  • TABLE 100: PRESCIENT SURGICAL INC. - AT A GLANCE
  • TABLE 101: COVALON TECHNOLOGIES LTD. - AT A GLANCE
  • TABLE 102: COVALON TECHNOLOGIES LTD. - KEY FINANCIAL SUMMARY
  • TABLE 103: SURGICAL SITE INFECTION PREVENTION LLC - AT A GLANCE
  • TABLE 104: MOLNLYCKE HEALTH CARE AB - AT A GLANCE
  • TABLE 105: MOLNLYCKE HEALTH CARE AB - KEY FINANCIAL SUMMARY
  • TABLE 106: HARTMANN GROUP - AT A GLANCE
  • TABLE 107: HARTMANN GROUP - KEY FINANCIAL SUMMARY
  • TABLE 108: NEX MEDICAL ANTISEPTICS SRL - AT A GLANCE
  • TABLE 109: MEDICA EUROPE BV - AT A GLANCE
  • TABLE 110: EXOXEMIS INC. - AT A GLANCE
  • TABLE 111: MEDI-LIN - AT A GLANCE
  • TABLE 112: WINNER MEDICAL CO. LTD. - AT A GLANCE
  • TABLE 113: SHALEX OVERSEAS PVT. LTD. - AT A GLANCE

List of Figures

  • FIG. 1: RESEARCH SCOPE
  • FIG. 2: RESEARCH METHODOLOGY
  • FIG. 3: REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG. 4: BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG. 5: BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG. 6: BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG. 7: DATA TRIANGULATION APPROACH
  • FIG. 8: GLOBAL SSI MARKET SUMMARY
  • FIG. 9: GERIATRIC POPULATION AS A PERCENTAGE OF TOTAL POPULATION
  • FIG. 10: DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • FIG. 11: RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • FIG. 12: PORTER'S FIVE FORCES ANALYSIS
  • FIG. 13: GLOBAL SSI MARKET SPLIT, BY PRODUCT (2017)
  • FIG. 14: GLOBAL SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 15: GLOBAL SSI MARKET SPLIT, BY PHASE (2017)
  • FIG. 16: GLOBAL SSI MARKET, BY PHASE, $M (2013-2023)
  • FIG. 17: GLOBAL INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 18: GLOBAL PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 19: GLOBAL POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 20: GLOBAL SSI MARKET SPLIT, BY END USER (2017)
  • FIG. 21: GLOBAL SSI MARKET, BY END USER, $M (2013-2023)
  • FIG. 22: NUMBER OF END USERS UTILIZING SSI PREVENTIVE PRODUCTS GLOBALLY (2017)
  • FIG. 23: WORLDWIDE MAJOR MARKETS FOR SSI
  • FIG. 24: NORTH MAERICA SSI MARKET SNAPSHOT
  • FIG. 25: NORTH AMERICA SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 26: NORTH AMERICA SSI MARKET, BY PHASE, $M (2013-2023)
  • FIG. 27: NORTH AMERICA INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 28: NORTH AMERICA PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 29: NORTH AMERICA POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 30: NORTH AMERICA SSI MARKET, BY END USER, $M (2013-2023)
  • FIG. 31: NUMBER OF END USERS UTILIZING SSI PREVENTIVE PRODUCTS IN NORTH AMERICA (2017)
  • FIG. 32: NORTH AMERICA SSI MARKET, BY COUNTRY, $M (2013-2023)
  • FIG. 33: EUROPE SSI MARKET SNAPSHOT
  • FIG. 34: EUROPE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 35: EUROPE SSI MARKET, BY PHASE, $M (2013-2023)
  • FIG. 36: EUROPE INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 37: EUROPE PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 38: EUROPE POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 39: EUROPE SSI MARKET, BY END USER, $M (2013-2023)
  • FIG. 40: NUMBER OF END USERS UTILIZING SSI PREVENTIVE PRODUCTS IN EUROPE (2017)
  • FIG. 41: EUROPE SSI MARKET, BY COUNTRY, $M (2013-2023)
  • FIG. 42: APAC SSI MARKET SNAPSHOT
  • FIG. 43: APAC SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 44: APAC SSI MARKET, BY PHASE, $M (2013-2023)
  • FIG. 45: APAC INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 46: APAC PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 47: APAC POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 48: APAC SSI MARKET, BY END USER, $M (2013-2023)
  • FIG. 49: NUMBER OF END USERS UTILIZING SSI PREVENTIVE PRODUCTS IN APAC (2017)
  • FIG. 50: APAC SSI MARKET, BY COUNTRY, $M (2013-2023)
  • FIG. 51: ROW SSI MARKET SNAPSHOT
  • FIG. 52: ROW SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 53: ROW SSI MARKET, BY PHASE, $M (2013-2023)
  • FIG. 54: ROW INTRAOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 55: ROW PREOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 56: ROW POSTOPERATIVE SSI MARKET, BY PRODUCT, $M (2013-2023)
  • FIG. 57: ROW SSI MARKET, BY END USER, $M (2013-2023)
  • FIG. 58: NUMBER OF END USERS UTILIZING SSI PREVENTIVE PRODUCTS IN ROW (2017)
  • FIG. 59: ROW SSI MARKET, BY COUNTRY, $M (2013-2023)
  • FIG. 60: GLOBAL SSI MARKET SHARE OF KEY PLAYERS (2017)
  • FIG. 61: PRODUCT BENCHMARKING OF KEY PLAYERS
  • FIG. 62: 3M COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)
  • FIG. 63: B. BRAUN MELSUNGEN AG - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2017)
  • FIG. 64: BECTON, DICKINSON AND COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)
  • FIG. 65: STERIS PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)
  • FIG. 66: STRYKER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)
  • FIG. 67: MEDTRONIC PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)
  • FIG. 68: HARTMANN GROUP - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)
Back to Top